DHL Global Forwarding, the air and ocean freight arm of Deutsche Post DHL Group, is implementing IATA’s CEIV Pharma Certification across its global facilities.
The first phase will include 30 of its global Air Thermonet facilities – and assessments are anticipated to begin in Q3 of this year.
The certification involves independent audits and training, and it includes the association’s Temperature Control Regulations (TCR), European Union Goods Distribution Practices (EU GDP), World Health Organisation Annex 5 and United States Pharmacopeia Standards.
“As global demand for structurally complex, temperature-sensitive pharmaceutical products grows, the life sciences and healthcare sector faces the challenges of increasingly stricter regulations and the need for smart cold chains that can secure product integrity and patients’ safety,” said David Bang, global head of DHL temperature management solutions, DHL Global Forwarding. “The IATA CEIV certification is yet another initiative within part of our continuous improvement activities to ensure our specialized and compliant network is up to the latest quality standard that recommends DHL as the right partner to the life sciences and healthcare sector.”
The freight company’s global forwarding station in Brussels has already rolled out the certification.
“DHL’s commitment to join the CEIV pharma program and certify its key global Thermonet facilities is good news for customers who can have even more confidence that their life-saving and temperature sensitive products will be delivered in impeccable condition,” said Glyn Hughes, IATA global head of cargo.” For the industry, it is another step towards achieving industry alignment and standardization across the pharmaceutical logistic supply chain, further enhancing the capabilities of the global pharma network,” said Glyn Hughes, IATA Global Head of Cargo.